SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX) -- Ignore unavailable to you. Want to Upgrade?


To: Stemwriter who wrote (122)7/28/1998 10:29:00 PM
From: Caveat Emptor  Respond to of 320
 
What is going on with ATROGEN?

Collaboration Agreement with Genzyme?

Time table for FDA Approval?




To: Stemwriter who wrote (122)7/29/1998 11:07:00 AM
From: Sam Lee  Read Replies (1) | Respond to of 320
 
Dead Cat Bounce

Arnx has enough money to last for one more year. Everyone knows that. Nothing will happen on this stock until a contract is announced. That is the future of the company. I am sure that management is as anxious as we are. But there is nothing to do but sit and wait.And hope.